Background -Bronchial inflammation in chronic bronchitis has not been characterised as well as in asthma. The present study was undertaken to assess whether a characteristic pattern of bronchial inflammatory markers could be found in patients with chronic bronchitis. Methods -Bronchoscopy with bronchial lavage was performed in 42 patients with chronic bronchitis and in 13 healthy controls. Twenty three of the patients had non-obstructive chronic bronchitis and 19 had chronic bronchitis and chronic obstructive pulmonary disease (COPD). Eighteen of the patients with bronchitis had recurrent infective exacerbations and 24 did not. Intrabronchial bacterial cultures were taken with a protected specimen brush. Results -Increased activity ofneutrophils, fibroblasts, and eosinophils was found in the patients with chronic bronchitis as assessed by the levels of myeloperoxidase (MPO) and interleukin-8 (IL-8), hyaluronan, and eosinophil cationic protein (ECP), respectively. The levels of tryptase did not differ from the controls. High correlations were found between the levels of MPO and IL-8, as well as ECP and IL-8. No differences were found between the patients with COPD and those with nonobstructive chronic bronchitis. Conclusions -Recruitment and activation of both neutrophils and eosinophils seem to be a characteristic ofchronic bronchitis. This activation is associated with IL-8. The patients with intrabronchial cultures of Streptococcus pneumoniae had the highest individual levels of MPO, ECP, and IL-8 of all subjects in the study, indicating that colonisation with Spneumoniae could promote bronchial inflammation. (Thorax 1995;50:360-365) 
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Chronic bronchitis is a clinical entity characterised by cough and mucus hypersecretion. It can be associated with bronchial obstruction (chronic obstructive pulmonary disease, COPD) and recurring infective exacerbations.'
The pathological changes in the respiratory tract consist of goblet cell hyperplasia and submucosal gland hypertrophy, as well as bronchial inflammation. 23 The airways inflammation in chronic bronchitis has not been characterised as well as in bronchial asthma. Histopathological studies of large airways mucosa in patients with chronic bronchitis have demonstrated infiltration of mononuclear phagocytes,4 lymphocyte infiltration, and lymphocyte activation.5 In contrast, mucosal changes in asthmatic patients have shown a predominance of eosinophils and mast cells. [6] [7] [8] [9] Bronchoalveolar lavage (BAL) fluid, as well as bronchial lavage fluid, from patients with chronic bronchitis has shown raised levels of macrophages and neutrophil granulocytes." 0 1
In lavage fluid from patients with chronic bronchitis one would therefore expect to find products from activated neutrophil granulocytes such as myeloperoxidase (MPO), and chemotactic factors for neutrophil granulocytes such as interleukin 8 (IL-8). In addition, since high levels of the acute phase reactant interleukin 6 (IL-6) have been found in the urine of patients with asymptomatic bacteriuria,2 this could also be a potential marker of local bacterial colonisation and bronchial mucosal inflammation in lavage fluid from patients with chronic bronchitis.
We wished to study whether the airways inflammation in smokers with chronic bronchitis is reflected in raised levels of inflammatory markers in bronchial lavage fluid compared with healthy non-smoking controls. The second aim was to determine whether levels of inflammatory markers differed between patients with non-obstructive chronic bronchitis and patients with chronic bronchitis and COPD, as well as between patients with chronic bronchitis and recurrent infective exacerbations and those without. The third objective was to assess whether the levels of markers correlated with the intrabronchial bacterial flora in the patient groups.
Methods

STUDY DESIGN
Small volume lavage of the large airways was used, a method known to give samples predominantly representative of the bronchial epithelium.'3 -`T he presence of MPO, tryptase, hyaluronan, and eosinophil cationic protein (ECP) were used as indirect markers for activation of neutrophils, mast cells, fibroblasts and eosinophils, respectively, and IL-6 and IL-8 were used to indicate a broader activation of cells including epithelial cells, granulocytes, and lymphocytes. All patients were investigated during an infection-free period. The patients with chronic bronchitis were slightly older and had a lower mean maximum FEV1 (percentage predicted normal) than the healthy controls. The smoking history (in pack years) and age between subgroups of patients with chronic bronchitis were comparable (table  1) .
Of the 23 patients with non-obstructive chronic bronchitis, none used oral N-acetylcysteine or inhaled medication on a regular basis. Ofthe 19 patients with chronic bronchitis and COPD, eight used oral N-acetylcysteine regularly (200 mg at least twice daily) and four used inhaled corticosteroids regularly. No patients used theophylline preparations or oral steroids.
The duration of symptoms in the patient group varied from 2-5 years to 24 years with a mean of 12-5 years. Criteria for exclusion were abnormal chest radiography, bronchial hypersecretion caused by factors other than cigarette smoking, a history of asthma or reversibility >10% after P2 agonists, and for safety reasons an FEV1 less than 50% predicted or age more than 70 years. Ventilatory function (FEV1) was measured with a Bernstein spirometer or Vitalograph.
The study design was approved by the ethical committee of the University of Goteborg and the volunteers gave their consent after both written and oral information.
FIBREOPTIC BRONCHOSCOPY
Premedication was given with haloperidol 5 mg orally followed by 0 5-1 ml morphine-scopolamine intramuscularly. Five ml 1 % tetracaine without preservative was nebulised (Plug-in inhalator, Aiolos Systems, Karlstad, Sweden) and inhaled in an upright position for local anaesthesia. All bronchoscopies were performed transorally by one of two experienced bronchoscopists, and with the patients in the supine position. Several fetal calf serum, and gentamicin (0.1 mg/ml) in a total volume of 0-2 ml. After 68-72 hours of culture 'H-thymidine was added, the incorporated radioactivity was measured and compared with a standard curve. The standard curve was prepared using stock recombinant human IL-6 (8000 units/ml; 1 unit = concentration of IL-6 required for a half maximal thymidine incorporation). The activities ofeach sample are given as units/ml compared with the standard curve.
IL-8 was analysed using a solid phase double ligand ELISA prototype method. Briefly, the bronchial lavage fluid was incubated in microtitre wells coated with a mouse monoclonal antibody against IL-8. All samples were diluted in the standard dilution buffer. After washing a goat anti-IL-8 horseradish peroxidase conjugate was added and the plates were incubated. The amount of IL-8 was measured spectrophotometrically after adding tetramethylbenzidine as enzyme substrate. Recombinant IL-825 was used as standard, ranging from 25 ng/l to 1600 ng/l. The intra-assay and interassay coefficients of variation were less then 10% and the detection limit was 10 ng/l.
DATA ANALYSIS
Results are expressed as arithmetic mean, median, and standard deviations (SD). The Kruskal-Wallis test was used to analyse the significance of differences in data between the controls, the patients with non-obstructive chronic bronchitis, and the patients with chronic bronchitis and COPD. The MannWhitney U test was used for the comparison of the distribution of the inflammatory markers between subgroups ofsubjects, and Spearman's rank correlation test for possible associations between markers. Multiple regression was performed to analyse the possible interdependence of clinical factors and inflammatory markers. Bonferroni's correction for the risk of mass significance with multiple comparisons between the four subgroups (B(la), B(lb), B(2a), and B(2b)) was performed.
Results
INFLAMMATORY MARKERS IN CONTROLS AND PATIENTS WITH CHRONIC BRONCHITIS
The patients with chronic bronchitis (group B) had significantly higher mean levels of MPO (p<0.01), IL-8 (p<0-01), hyaluronan (p<0Q001), and ECP (p<0001) than the controls (figs 1 and 2) . The mean levels of tryptase, IL-6, and albumin did not differ statistically between the patients with chronic bronchitis and the controls.
When albumin values were used as a denominator for each marker the differences in levels of markers between the groups were still present, but the statistical significances were lost (data not shown).
INFLAMMATORY MARKERS IN PATIENTS WITH AND WITHOUT AIRWAYS OBSTRUCTION
The patients with chronic bronchitis and COPD (subgroup B(lb)) did not differ in levels Two of the three patients with intrabronchial cultures of Streptococcus pneumoniae were found to have the highest individual levels of MPO, IL-8, and ECP of all subjects in the study (table  3) . The levels of markers in the two patients with cultures of Haemophilus influenzae, and in those with significant growth of other bacterial strains, were similar to the levels in the patients without significant intrabronchial bacterial growth (table 3) . The significant differences in mean levels of MPO, IL-8, hyaluronan, and ECP between the patients with chronic bronchitis and COPD compared with the controls were still valid when the high values for the patients with intrabronchial cultures of Streptococcus pneumoniae had been subtracted.
CORRELATIONS BETWEEN PARAMETERS
Highly significant correlations were found between the ECP and MPO levels (rho=0O74; p<0-001, Spearman's rank test) and the ECP and IL-8 levels (rho=075; p<0*001, Spearman's rank test). The correlation between MPO and IL-8 levels was also highly significant (rho=0-87; p<0-001, Spearman's rank test) (fig 3) . The levels of tryptase, hyaluronan, and albumin showed no correlation with any of the other markers.
None of the clinical paramaeters -age, smoking habits., airway medication includingN-acetylcysteine, duration of bronchitis symptoms, or lung function (FEVy percentage predicted normal) -had any correlations with the markers studied.
Discussion
In this study significantly higher activity of neutrophils, fibroblasts, and eosinophils as assessed by levels of MPO, IL-8, hyaluronan, and ECP, respectively, were found in bronchial lavage fluid samples from smokers with chronic bronchitis than from healthy non-smoking controls. However, the levels of tryptase -a mediator known to be related to the activation of mast cells and found in high levels in asthmatics26 -were similar between the two groups. Earlier findings in bronchoalveolar lavage fluid from patients with chronic bronchitis have disclosed an increased recovery ofmacrophages and neutrophils,27 and the first bronchial fraction of the lavage gives the highest neutrophil numbers.'0 Furthermore, the number of neutrophils in the airways correlated well with airways obstruction (FEVI) and increased sputum production.'027 Our results revealed high levels of MPO, previously shown to be of local origin,28 in bronchial lavage fluid from patients with chronic bronchitis, suggesting that activated neutrophil granulocytes take part in the airways inflammation in these patients. We also found significantly raised levels of IL-8 in the patients, which is in accordance with a recent study reporting high levels of IL-8 in sputum from patients with chronic bronchitis.9 IL-8 is a cytokine with chemotactic effects on neutrophil granulocytes29 produced by alveolar macrophages and respiratory epithelium." The high correlation found between the levels of MPO and IL-8 in the present study supports the hypothesis that a specific attraction and activation of neutrophils is present in the airways inflammatory process in patients with chronic bronchitis.
Our results support those of Linden et al who reported increased levels of both ECP and MPO in bronchoalveolar lavage fluid from patients with chronic bronchitis and COPD."
The high levels of ECP found in the present study, together with the strong correlations between ECP and MPO, and ECP and IL-8 respectively, support in vitro data that IL-8 not only attracts and activates neutrophils, but also eosinophil granulocytes."2 Thus, airways inflammation in chronic bronchitis is characterised by a broad activation of mucosal granulocytes including eosinophils.
Free hyaluronan, a marker for activated fibroblasts, was significantly raised in the patients with chronic bronchitis in our study. It was not correlated with airways obstruction, as seen in asthmatic patients,33 but it was the only mediator to be raised, although not significantly, in patients with a history of recurrent infective exacerbations as opposed to those without.
No specific marker correlated with the development of airways obstruction and COPD. No significant differences were found between the patients with non-obstructive chronic bronchitis and patients with COPD, and no convincing correlations were seen between the levels of markers and FEV, values.
Interleukin 6 (IL-6) is a multifunctional cytokine produced by most nucleated cells. It has been found in the urine of patients with asymptomatic bacteriuria" and in patients deliberately colonised with Escherichia coli. 34 We could, however, find no difference in the levels of IL-6 between the subjects in this study, although several patients had an intrabronchial bacterial colonisation. 8 To obtain samples which predominantly reflect the status of the bronchial epithelium, small volume lavage (<20 ml) in the large airways is of more value than the traditional large lavage.'3-'5 We used a single instillation of 5 ml to minimise the risk of alveolar "contamination". In agreement with Bousquet et al33 we chose to present our data as the concentration of lavaged fluid because (a) the instilled volume was always the same, and (b) no gold standard to compensate for the dilution of the lavaged fluid is valid.3536 When we used albumin as the denominator for each marker the differences found between the groups were still present, but not statistically significant. However, previous studies found the use of urea or albumin as denominators of protein ratios for the local concentration of markers in lavaged fluid to be inappropriate.'738 The similar levels of tryptase, IL-6, and albumin in the subject groups studied also suggest that our data reflect differences in other markers that are not artefactual.
There are some additional methodological 
